Publications

Export 91 results:
Filters: Author is Roy, Marc-André  [Clear All Filters]
2022
Association between previous and future antipsychotic adherence in patients initiating clozapine: real-world observational study., Br J Psychiatry, pp. 1-8, 2022.
Comparative effectiveness and safety of antipsychotic drugs in patients with schizophrenia initiating or reinitiating treatment: A Real-World Observational Study., Acta Psychiatr Scand, vol. 145, no. 5, pp. 456-468, 2022.
A. LeBlanc, Baron, M., Blouin, P., Tarabulsy, G., Routhier, F., Mercier, C., Després, J. - P., Hébert, M., De Koninck, Y., Cellard, C., Collin-Vézina, D., Côté, N., Dionne, É., Fleet, R., Gagné, M. - H., Isabelle, M., Lessard, L., Menear, M., Mérette, C., Ouellet, M. - C., Roy, M. - A., Saint-Jacques, M. - C., and Savard, C., For a structured response to the psychosocial consequences of the restrictive measures imposed by the global COVID-19 health pandemic: the MAVIPAN longitudinal prospective cohort study protocol., BMJ Open, vol. 12, no. 4, p. e048749, 2022.
Management of Rhabdomyolysis in a Patient Treated with Clozapine: A Case Report and Clinical Recommendations., Clin Psychopharmacol Neurosci, vol. 20, no. 1, pp. 194-198, 2022.
What areas of everyday functioning are affected by theory of mind deficits in recent-onset schizophrenia spectrum disorders?, Early Interv Psychiatry, 2022.
2021
Sante Ment Que, vol. 46, no. 2, pp. 19-21, 2021.
L. - D. Leclerc, Demers, M. - F., Bardell, A., Bilodeau, I., Williams, R., Tibbo, P., and M-A Roy, A Chart Audit Study of Clozapine Utilization in Early Psychosis., J Clin Psychopharmacol, vol. 41, no. 3, pp. 275-280, 2021.
L. Béchard, Corbeil, O., Plante, M., Thivierge, M. - A., Lafrenière, C. - É., M-A Roy, and Demers, M. - F., Clozapine rechallenge following neutropenia using granulocyte colony-stimulating factor: A Quebec case series., J Psychopharmacol, vol. 35, no. 9, pp. 1152-1157, 2021.
[Detecting and Treating Comorbid Disorders in First-Episode Psychosis: A Lever for Recovery]., Sante Ment Que, vol. 46, no. 2, pp. 307-330, 2021.
[Early Intervention for Psychosis from Past to Future: Overcoming Implementation Challenges to Maximize its Impact?], Sante Ment Que, vol. 46, no. 2, pp. 391-415, 2021.
[Family Approaches in Early Intervention: Benchmarks to Guide Intervention and Support Families in First Episode Psychosis Programs (FEPP)]., Sante Ment Que, vol. 46, no. 2, pp. 139-159, 2021.
[From Kraepelin to McGorry: Scientific Vision and Experiential Narrative around a Major Paradigmatic Shift]., Sante Ment Que, vol. 46, no. 2, pp. 23-43, 2021.
[A Healthy Mind in a Healthy Body: The Value of Physical Activity for Youth With First Episode Psychosis]., Sante Ment Que, vol. 46, no. 2, pp. 249-276, 2021.
O. Corbeil, Corbeil, S., Dorval, M., Carmichael, P. - H., Giroux, I., Jacques, C., Demers, M. - F., and M-A Roy, Problem Gambling Associated with Aripiprazole: A Nested Case-Control Study in a First-Episode Psychosis Program., CNS Drugs, vol. 35, no. 4, pp. 461-468, 2021.
[Psychopharmacology of First Episode Psychosis: An Approach Based on Recovery]., Sante Ment Que, vol. 46, no. 2, pp. 113-137, 2021.
A. Lesage, Courteau, J., Brodeur, S., Stip, E., Fleury, M. - J., Courteau, M., M-A Roy, and Vanasse, A., Urbanicity, Schizophrenia and Equitable Specialist Services Allocation., Can J Psychiatry, p. 7067437211040606, 2021.
2020
M. - A. Nolin, Demers, M. - F., Rauzier, C., Bouchard, R. - H., Cadrin, C., Després, J. - P., M-A Roy, Alméras, N., and Picard, F., Circulating IGFBP-2 levels reveal atherogenic metabolic risk in schizophrenic patients using atypical antipsychotics., World J Biol Psychiatry, pp. 1-8, 2020.
M-A Roy, The Evolution of Long-Acting Antipsychotics Use in Québec between 2003 and 2017., Can J Psychiatry, vol. 65, no. 7, pp. 510-511, 2020.
E. Stip, Grignon, S., M-A Roy, Bloom, D., Osman, O., Amiri, L., Aziz, K. Abdul, Javaid, S. Fahad, and Arnone, D., From QAAPAPLE 1 to QAAPAPLE 2: How do we move from one algorithm to another one with Long acting antipsychotics (LAIs)., Expert Rev Neurother, 2020.
P. Gagnon, Gaudreau, J. - D., M-A Roy, and Moreau, J. Le Moignan, Letter to the Editor: Correction About the Nursing Delirium Screening Scale in Response to: "A Study of the Psychometric Properties of the "Stanford Proxy Test for Delirium" (S-PTD): A New Screening Tool for the Detection of Delirium"., Psychosomatics, 2020.
Y. C. Chagnon, Maziade, M., Paccalet, T., Croteau, J., Fournier, A., M-A Roy, and Bureau, A., A multimodal attempt to follow-up linkage regions using RNA expression, SNPs and CpG methylation in schizophrenia and bipolar disorder kindreds., Eur J Hum Genet, vol. 28, no. 4, pp. 499-507, 2020.
W. Pothier, M-A Roy, Corbière, M., Thibaudeau, É., Achim, A., Wykes, T., Reeder, C., Chagnon, Y., and Cellard, C., Personalized cognitive remediation therapy to facilitate return to work or to school in recent-onset psychosis., Neurocase, vol. 26, no. 6, pp. 340-352, 2020.
O. Corbeil, Corbeil, S., Giroux, I., Jacques, C., Dorval, M., Demers, M. - F., and M-A Roy, Problem Gambling Associated With Aripiprazole in First-Episode Psychosis Patients: A Series of 6 Case Reports., J Clin Psychopharmacol, vol. 40, no. 2, pp. 191-194, 2020.
V. Ferraro, Lafrenière, S., Demers, M. - F., M-A Roy, and Abdel-Baki, A., "Real world" clinical effectiveness of paliperidone palmitate 3-monthly injectable in early psychosis patients., Psychopharmacology (Berl), 2020.

Funding / Support / Partners

logo FRQ-S logo ctrn logo fci logo cihr irsc logo nserc logo MESISentinelle nord